Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

DOBUTAMINE INJECTION USP 12.5 MG

DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) : 12.5 MG · DIN 02462729 · HIKMA CANADA LIMITED

Health Canada status: MARKETED

What is DOBUTAMINE INJECTION USP?

DOBUTAMINE INJECTION USP 12.5 MG contains DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) : 12.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02462729, held by HIKMA CANADA LIMITED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 12-Jul-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is DOBUTAMINE INJECTION USP used for?

Dobutamine Injection USP is indicated in the treatment of adults with cardiac decompensation due to depressed contractility resulting from organic heart disease or following cardiac surgical procedures in which parenteral therapy is necessary for inotropic support.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02462729
Brand nameDOBUTAMINE INJECTION USP
Generic / active ingredientDOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) : 12.5 MG
ManufacturerHIKMA CANADA LIMITED
Strength12.5 MG
Dosage formSOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeC01CA07 DOBUTAMINE
BiosimilarNo
Health Canada statusMARKETED
Status date12-Jul-2024

How is it stored and handled?

Store unopened vial between 15 and 30°C. Protect from light. Store diluted solution up to 24 hours at room temperature (15-30°C).

How is it supplied?

20 mL single use vials, boxes of 10.

What can be used instead?

Other Canadian products sharing ATC code C01CA07 DOBUTAMINE. 2 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
DOBUTAMINE INJECTION USP12.5 MGLIQUIDSANDOZ CANADA INCORPORATEDMARKETEDDIN 02242010
DOBUTAMINE 12.5MG/ML12.5 MGSOLUTIONIVAX PHARMACEUTICALS INCORPORATEDCANCELLED POST MARKETDIN 02229451
DOBUTAMINE HYDROCHLORIDE INJECTION-12.5MG/ML12.5 MGLIQUIDSANOFI CANADA, INC.CANCELLED POST MARKETDIN 02225891
DOBUTAMINE HYDROCHLORIDE INJECTION-12.5MG/ML12.5 MGLIQUIDNOVOPHARM LIMITEDCANCELLED POST MARKETDIN 02228335
DOBUTAMINE INJECTION SDZ12.5 MGSOLUTIONSANDOZ CANADA INCORPORATEDDORMANTDIN 02384671
DOBUTAMINE INJECTION USP12.5 MGSOLUTIONSTERIMAX INCAPPROVEDDIN 02443430
DOBUTAMINE INJECTION USP250 MG / 20 MLSOLUTIONPFIZER CANADA ULCCANCELLED POST MARKETDIN 02210401
DOBUTREX12.5 MGSOLUTIONPHARMACEUTICAL PARTNERS OF CANADA INCCANCELLED POST MARKETDIN 00759538

Who else supplies DOBUTAMINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. DOBUTAMINE appears in 17 registered pack listings across 6 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for DOBUTAMINE INJECTION USP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for DOBUTAMINE INJECTION USP

Health Canada Drug Product Database (DPD), DIN 02462729. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.